Martinez-Lopez, Joaquin http://orcid.org/0000-0001-7908-0063
Alonso, Rafael
Wong, Sandy W.
Rios, Rafael
Shah, Nina
Ruiz-Heredia, Yanira
Sanchez-Pina, Jose Maria
Sanchez, Ricardo
Bahri, Natasha
Zamanillo, Irene
Poza, Maria
Buenache, Natalia
Encinas, Cristina
Juarez, Luis
Miras, Fatima
Collado, Luis
Barrio, Santiago
Martin, Thomas
Cedena, Maria Teresa
Wolf, Jeffrey
Funding for this research was provided by:
cris against the cancer (18001)
Article History
Received: 29 June 2021
Accepted: 4 August 2021
First Online: 17 August 2021
Declarations
:
: The study was approved by the Institutional Review Board (IRB) of University Hospital 12 de Octubre (n# 20/326) and UCSF. Written informed consent was waived in light of the retrospective nature and need to collect and report data.
: Not applicable.
: JML. Speaking bureau of Adaptive, owner of shares of Altum sequencing and Hosea. JW. Consultant for Adaptive. SB. Owner of shares of Altum sequencing. RA, RR, NS, YRH, JMSP, RS, NB, IZ, MP, NB, CE, LJ, FM, LC, TM declare no competing financial interests, this must be explicitly stated and will be included in all versions of the article.